Lipid-modifying therapy reduces cardiovascular disease (CVD) risk in many patients, especially in those with pre-existing CVD. Lipid- lowering therapies include statins, ezetimibe and PCSK9 inhibitors, with promising new therapies currently in development.
Anthony P. Sunjaya, Leanne M. Poulos, Helen K. Reddel, Christine R. Jenkins
A 37-year-old teacher presents with breathlessness on exertion that has been affecting her ability to exercise over the past three years. How would you investigate and manage her?
The term ‘nociplastic pain’ has been introduced as the third mechanistic descriptor for the somatic component of pain. This article defines this new term and explains the significance of its introduction.
Although pharmacotherapies are the cornerstone of managing advanced cancer pain, other biological and nonpharmacological therapies can be used in conjunction to further relieve pain.
New daily persistent headache (NDPH) is under-recognised in the community. Early diagnosis and a multidisciplinary approach to management can help patients understand the condition and strengthen the therapeutic relationship.